van Dongen, Guus A.M.S.
Vrije Universiteit Amsterdam,
Netherlands
2024 Rank: 122774
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 643 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122774 | 118888 |
| Total Cites | 796 | 874 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 31 | 37 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 253 | 264 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 532 | 562 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.56 |
| Self-Citation Percentage |
8.92%
|
|
van Dongen, Guus A.M.S.
Vrije Universiteit Amsterdam,
Netherlands
2023 Rank: 137682
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 791 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137682 | 140996 |
| Total Cites | 939 | 1032 |
| H-index | 14 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 47 | 55 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 306 | 332 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 587 | 628 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.64 |
| Self-Citation Percentage |
9.01%
|
|
van Dongen, Guus A.M.S.
Vrije Universiteit Amsterdam,
Netherlands
2022 Rank: 111088
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4162 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 111088 | 117526 |
| Total Cites | 963 | 1079 |
| H-index | 16 | 17 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 46 | 49 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 368 | 412 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 594 | 635 |
| Ratio of Total Citations to Distinct Citing Papers | 1.62 | 1.70 |
| Self-Citation Percentage |
10.75%
|
|
van Dongen, Guus A.M.S.
Vrije Universiteit Amsterdam,
Netherlands
2021 Rank: 122598
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4372 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 122598 | 130177 |
| Total Cites | 1393 | 1529 |
| H-index | 19 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 63 | 69 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 565 | 615 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 878 | 934 |
| Ratio of Total Citations to Distinct Citing Papers | 1.59 | 1.64 |
| Self-Citation Percentage |
8.89%
|
|